ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 61 filers reported holding ADC THERAPEUTICS SA in Q2 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $67,000 | -45.5% | 13,945 | -10.1% | 0.02% | -41.9% |
Q2 2022 | $123,000 | -46.1% | 15,515 | 0.0% | 0.04% | -39.4% |
Q1 2022 | $228,000 | -26.0% | 15,515 | +1.8% | 0.07% | -12.3% |
Q4 2021 | $308,000 | -23.4% | 15,245 | +3.0% | 0.08% | -25.7% |
Q3 2021 | $402,000 | -3.1% | 14,805 | -13.0% | 0.11% | -6.8% |
Q2 2021 | $415,000 | +8.4% | 17,025 | +8.5% | 0.12% | -0.8% |
Q1 2021 | $383,000 | +11.0% | 15,686 | +45.6% | 0.12% | +9.3% |
Q4 2020 | $345,000 | +47.4% | 10,775 | +52.1% | 0.11% | +25.6% |
Q3 2020 | $234,000 | +2.6% | 7,085 | +45.6% | 0.09% | -4.4% |
Q2 2020 | $228,000 | – | 4,865 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vantage Consulting Group Inc | 1,680,149 | $33,939,000 | 9.12% |
Redmile Group, LLC | 7,451,029 | $150,511,000 | 3.42% |
Grosvenor Holdings, L.L.C. | 1,517,212 | $30,648,000 | 3.17% |
Indie Asset Partners, LLC | 96,582 | $1,951,000 | 1.42% |
MPM BioImpact LLC | 337,396 | $6,815,000 | 1.24% |
Eventide Asset Management | 1,975,000 | $39,895,000 | 0.51% |
HHLR ADVISORS, LTD. | 500,000 | $10,100,000 | 0.16% |
Virtus ETF Advisers LLC | 19,193 | $388,000 | 0.15% |
CNA FINANCIAL CORP | 15,245 | $308,000 | 0.08% |
Employees Retirement System of Texas | 278,000 | $5,616,000 | 0.06% |